115 Proteins Enriched at Mouse Diaphragm Nerve–Muscle Junctions

A protein map of mouse diaphragm identified 115 proteins enriched at neuromuscular junctions, the contact points where nerves communicate with muscle. It also identified 31 proteins shared between nerve–muscle and muscle–tendon junction protein patterns. Enriched means more abundant in a region, not necessarily unique to it.

Evidence

The mouse diaphragm junction-mapping study, published September 18, 2026, examined the diaphragm’s medial costal region. This is a single-study report in mice, not a comparison of independent studies.

Researchers used spatial proteomics—measuring many proteins while retaining information about their location—to examine thin frozen sections along the muscle fiber–tendon axis. Short liquid chromatography–mass spectrometry runs, which separate and identify molecular components, generated approximately 2,500 protein profiles. That figure describes protein profiles, not the number of animals. Comparing anatomical regions distinguished proteins enriched at nerve–muscle junctions from proteins shared with myotendinous junctions, where muscle meets tendon.

Proteomics and immunostaining, which uses antibodies to locate proteins in tissue, supported closer examination of FXYD6. This protein localized to the cell membrane in the nerve–muscle-junction region and was associated with different forms of the sodium–potassium pump in muscle and nerve cells. The pump moves sodium and potassium across cell membranes. The study also reported enhanced FXYD6 expression in type IIa fibers, a muscle-fiber subtype.

Analysis

Interpretation: The atlas connects anatomical location with distinct and overlapping protein patterns. The 31 shared proteins are compatible with some shared structural features between the two junction types, but do not establish identical functions.

FXYD6 emerges as a candidate protein spanning both junction types. Its location and pump associations provide a reason to investigate regulation, not proof that regulation occurs. The study’s relevance to respiratory and neuromuscular disease is biological context: it maps structures of interest without establishing a disease mechanism, diagnostic marker, or treatment effect.

Limitations

The available study details do not specify animal sample size, numerical enrichment effect sizes, or statistical uncertainty. The counts therefore describe the atlas rather than the magnitude or precision of a functional effect. Tiny junctions are also difficult to isolate from surrounding muscle tissue.

Mouse diaphragm findings do not establish the same patterns in humans. Whether FXYD6 regulates pump activity at the muscle membrane adjoining nerves remains unresolved, as does whether any such regulation is specific to nerve-contact regions rather than other parts of the muscle fiber.

What to watch

Reproduction of the enrichment patterns across animals, with sample sizes and uncertainty reported, would strengthen confidence in the atlas. For the proposed FXYD6 mechanism, confidence would change with a direct measurement of whether altering FXYD6 changes sodium–potassium pump activity preferentially at nerve-contact regions rather than elsewhere on the muscle fiber.